Project Number 5R01AG041502-02 Agency/Funding Organization NIA Funding Year 2013 View Full Project Details for CITALOPRAM DECREASES CSF AB: A RANDOMIZED DOSE FINDING TRIAL Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) t. Other Researcher and Organization Principal Investigator SHELINE, YVETTE I Principal Investigator First Name YVETTE I Principal Investigator Last Name SHELINE Awardee Organization WASHINGTON UNIVERSITY IN SAINT LOUIS Awardee State Missouri Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-11-100: Alzheimer's Disease Pilot Clinical Trials (R01) FY Overall Cost $11,624 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Related Resources Clinical Trial Escitalopram Effects on CSF Amyloid Beta
